---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-022794"
form_type: "8-K"
ticker: null
cik: "0001165320"
company_name: "GB SCIENCES INC"
filed_at: "2024-07-16T23:59:59+00:00"
generated_at: "2026-05-31T20:23:39.449084+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GB Sciences appoints Dr. Small-Howard as CEO, CFO, Chairman after John Poss's death

## Summary
- John Poss passed away on July 10, 2024; he led GB Sciences as CEO and Chairman since 2015.
- Dr. Andrea Small-Howard promoted to CEO, CFO, and Chairman under a pre-established succession plan.
- Dr. Small-Howard previously served as President for three years, overseeing day-to-day operations.
- She is a founding board member and the architect of the company's cannabinoid medicine strategy.

## SEC filing metadata
- accession: 0001437749-24-022794
- form_type: 8-K
- cik: 0001165320
- company_name: GB SCIENCES INC
- filed_at: 2024-07-16T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1165320/000143774924022794/0001437749-24-022794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1165320/000143774924022794/gblx20240716_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-022794
- JSON: https://secwatch.observer/filing/0001437749-24-022794.json
- Plain text: https://secwatch.observer/filing/0001437749-24-022794.txt

## Key facts
- Executive change
  Dr. Andrea Small-Howard was appointed as Chief Executive Officer, Chief Financial Officer, and Chairman at GB SCIENCES INC.
  - Action: promoted
  - Role: Chief Executive Officer, Chief Financial Officer, and Chairman
  source text: She was promoted to CEO, CFO and Chairman of the Board as a part of their succession plan, which was created due to the failing health of Mr. John Poss.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1165320/000143774924022794/0001437749-24-022794-index.htm
- Executive change
  John Poss departed as Chief Executive Officer and Chairman at GB SCIENCES INC.
  - Action: passed away
  - Role: Chief Executive Officer and Chairman
  source text: Mr. Poss had battled through serious health issues and had served the company very well since 2015. Fortunately, Mr. Poss had spent years preparing Dr. Small-Howard for her expanded role as CEO, CFO and Chairman, which roles fell to her upon the passing of Mr. Poss on July 10, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1165320/000143774924022794/0001437749-24-022794-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.